Top

Q -- Megestron - Injectable Contraceptive

Active

M-OAA-GH-05-1556Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

The U.S. Agency for International Development (USAID) plans to award a sole-source contract to Organon NV for a period of approximately 14 months starting around October 25, 2005, with an estimated contract value between $3 million and $4 million. This contract will secure the supply of 3 to 4 million vials of Megestron, a three-month injectable contraceptive containing Depot Medroxyprogesterone Acetate (DMPA), for use in USAID-supported family planning programs worldwide. Megestron, comparable to Depo-Provera, has been approved by a stringent regulatory authority equivalent to the U.S. FDA and is registered in about 35 countries. The product is offered as a public sector presentation including auto-disable syringes and sharps disposal containers, providing an essential and low-cost contraceptive option that supports the continuity and expansion of family planning initiatives. USAID’s selection of Megestron is based on its ability to meet critical supply requirements and provide an alternative injectable contraceptive source for the agency’s programs. The procurement falls under authorized source code 935, allowing sourcing from any country except those with foreign policy restrictions. Though this is a sole-source procurement under FAR 6.302, the agency invites interested parties to express capability or interest within 30 days of the announcement, with any decision not to compete resting solely with the government. The primary contacts for this contract are Contracting Officers Marjan A. Zanganeh and Bruce L. Baltas, both reachable via the provided USAID email addresses and phone numbers.

General Info

USAID awards sole-source contract to Organon NV for $3-4M injectable contraceptive supply.

Agency

Agency For International Development → Usaid M/oaa

NAICS

339999 - All Other Miscellaneous Manufacturing

Place of Performance

Set-Aside

NONE

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedJun 16

special-notice

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyAgency For International Development → Usaid M/oaa

Contacts2 people available

OfficeWASHINGTON, DC, 20004, USA

Organization / AgencyAgency For International Development → Usaid M/oaa

Office AddressWASHINGTON, DC, 20004, USA

Contacts

Marjan A ZanganehContracting Officer

contact@example.gov

+1 (555) 000-0000

Bruce L BaltasContracting Officer

contact@example.gov

+1 (555) 000-0000

Full Description

The U.S. Agency for International Development (USAID) intends to award a sole-source contract to Organon NV for approximately 14 months beginning on or about October 25, 2005 at an estimated price of $3,000,000 - $4,000,000. The contract will enable USAID to receive 3,000,000 - 4,000,000 vials of Megestron from the manufacturer for USAID-supported family planning programs. The availability of an injectable contraceptive is an essential element to the continued success of USAID-supported family planning program. USAID has selected Megestron because it meets basic requirements for supply. Megestron is a three-month injectable contraceptive of DMPA (Depot Medroxyprogesterone Acetate) comparable to Depo-Provera, which is distributed to USAID- support family planning programs worldwide. This product has been approved by a stringent regulatory authority; it is approved for use in Europe and many other countries by the Medical Evaluation Board in Amsterdam, which in Holland is the equivalent of the U.S. Food and Drug Administration. Megeston is available for immediate delivery in USAID's public sector presentation which bundles the DMPA with auto-disable syringes and sharps disposal containers. This product has been registered in approximately 35 countries in which USAID currently supplies DMPA and is available at a low public sector price. Megestron will provide the Agency with an alternative injectable source to provide supplies to family planning programs that USAID currently supports. The authorized source and origin code for this procurement is 935 (any country or area excluding foreign policy-restricted countries). USAID intends to solicit and negotiate with only one source under the authority of FAR 6.302. Interested persons may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive proposals. However, all statements of interest received within thirty days after the date of publication of this notice will be considered by the Government. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement.